This commentary in The Journal of Infectious Diseases authored by members of The Company’s Advisory Team speaks to the efficacy of Grignard Pure against the SARS-CoV-2 virus.

Authors: Manny Goldman,  Gedi Mainelis, Toni Choueiri, Ram Ramachandran, Don Schaffner

Leave a Reply

Your email address will not be published. Required fields are marked *

Post comment